1-6 of 6
Rémi Buisson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 137: Epigenetic regulation of APOBEC3A mutagenesis and tumor evolution during targeted therapy in non-small cell lung cancer

Hideko Isozaki, Ramin Sakhtemani, Naveed Nikpour, Susanna Monroe, Jessica Lin, Lecia Sequist, Zofia Piotrowska, Justin Gainor, Rémi Buisson, Michael Lawrence, Aaron Hata
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 137.
https://doi.org/10.1158/1538-7445.AM2023-137
Published: 04 April 2023
View articletitled, Abstract 137: Epigenetic regulation of APOBEC3A mutagenesis and tumor evolution during targeted therapy in non-small cell lung cancer
Journal Articles

Abstract 657: Impact of therapy induced APOBEC3A mutagenesis on tumor evolution in non small cell lung cancer

Hideko Isozaki, Ammal Abbasi, Naveed Nikpour, Marcello Stanzione, Ramin Sakhtemani, Susanna L. Monroe, Alice T. Shaw, Jessica J. Lin, Lecia V. Sequist, Zofia Piotrowska, Rémi Buisson, Michael S. Lawrence, Aaron N. Hata
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 657.
https://doi.org/10.1158/1538-7445.AM2022-657
Published: 15 June 2022
View articletitled, Abstract 657: Impact of therapy induced APOBEC3A mutagenesis on tumor evolution in non small cell lung cancer
Journal Articles

Abstract 39: APOBEC3A drives acquired resistance to targeted therapies in non small cell lung cancer

Hideko Isozaki, Ammal Abbasi, Naveed Nikpour, Adam Langenbucher, Wenjia Su, Marcello Stanzione, Lecia V. Sequist, Rémi Buisson, Michael S. Lawrence, Aaron N. Hata
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 39.
https://doi.org/10.1158/1538-7445.AM2021-39
Published: 01 July 2021
View articletitled, Abstract 39: APOBEC3A drives acquired resistance to targeted therapies in non small cell lung cancer
Journal Articles

Abstract PR09: Cancer-specific retargeting of BAF complexes by a prion-like domain

Gaylor Boulay, Gabriel J. Sandoval, Nicolo Riggi, Sowmya Iyer, Rémi Buisson, Beverly Naigles, Mary E. Awad, Shruthi Rengarajan, Angela Volorio, Matthew J. McBride, Liliane C. Broye, Lee Zou, Ivan Stamenkovic, Cigall Kadoch, Miguel N. Rivera
Journal: Cancer Research
Cancer Res (2018) 78 (19_Supplement): PR09.
https://doi.org/10.1158/1538-7445.PEDCA17-PR09
Published: 01 October 2018
View articletitled, Abstract PR09: Cancer-specific retargeting of BAF complexes by a prion-like domain
Journal Articles

Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells

François Bélanger, Emile Fortier, Maxime Dubé, Jean-François Lemay, Rémi Buisson, Jean-Yves Masson, Abdelhamid Elsherbiny, Santiago Costantino, Euridice Carmona, Anne-Marie Mes-Masson, Hugo Wurtele, Elliot Drobetsky
Journal: Cancer Research
Cancer Res (2018) 78 (19): 5561–5573.
https://doi.org/10.1158/0008-5472.CAN-18-0618
Published: 01 October 2018
View articletitled, Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells
Open the PDF for Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells in another window
Includes: Supplementary data
Journal Articles

APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition

Rémi Buisson, Michael S. Lawrence, Cyril H. Benes, Lee Zou
Journal: Cancer Research
Cancer Res (2017) 77 (17): 4567–4578.
https://doi.org/10.1158/0008-5472.CAN-16-3389
Published: 31 August 2017
View articletitled, APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition
Open the PDF for APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition in another window
Includes: Supplementary data